Seda S Tolu
Overview
Explore the profile of Seda S Tolu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
518
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tolu S, Viny A, Amengual J, Pro B, Bates S
Nat Rev Clin Oncol
. 2024 Dec;
22(2):117-133.
PMID: 39623073
Rapid advances in the field of epigenetics have facilitated the development of novel therapeutics targeting epigenetic mechanisms that are hijacked by cancer cells to support tumour growth and progression. Several...
2.
Patel R, Negassa A, Tolu S, Acuna-Villaorduna A, Goel S
Clin Colorectal Cancer
. 2023 Nov;
23(1):14-21.e1.
PMID: 37919185
Background: Randomized clinical trials have defined the survival advantage with the addition of biologic drugs to chemotherapy in patients with metastatic colorectal cancer (mCRC). Under representation of Hispanics contributes to...
3.
4.
Tolu S, Van Doren L
Transfus Apher Sci
. 2022 Sep;
61(5):103533.
PMID: 36058780
Sickle cell disease (SCD) is the most common inherited red blood cell (RBC) disorder worldwide, resulting in chronic hemolytic anemia, vaso-occlusion, tissue hypoxia, and ultimately end organ damage. The hallmark...
5.
Chawla G, Tolu S, Arora S
BMJ Case Rep
. 2022 Mar;
15(3).
PMID: 35264384
We report a man in his 80s who presents with epigastric abdominal pain and fatigue for 2 weeks. His medical history was significant for left toe acral melanoma (excised 6 ...
6.
Tolu S, Crouch A, Choi J, Gao Q, Reyes-Gil M, Ogu U, et al.
Ann Hematol
. 2022 Jan;
101(3):541-548.
PMID: 35039901
The presence of leg ulcers in individuals with sickle cell disease often represents an early sign of vasculopathy and future end organ damage. Pathophysiological mechanisms of formation and evolution of...
7.
Gold J, Tolu S, Chiller T, Benedict K, Jackson B
Clin Infect Dis
. 2021 Dec;
75(2):334-337.
PMID: 34893821
We analyzed administrative data to determine the 1-year incidence of invasive fungal infections (IFIs) in patients beginning small molecule kinase inhibitor (SMKI) therapy. The incidence of IFIs by small molecule...
8.
Ogu U, Reyes Gil M, Tolu S, Acharya S, Minniti C
Hemoglobin
. 2021 Jun;
45(2):136-139.
PMID: 34134586
Sickle cell disease variants include hemoglobinopathies that result from inheritance of the sickle cell globin mutation with another globin mutation. The most common variants include the homozygous disease state (Hb...
9.
Minniti C, Tolu S, Wang K, Yan Z, Robert K, Zhang S, et al.
Cells
. 2020 Oct;
9(10).
PMID: 33003401
The concentration of circulating hematopoietic stem and progenitor cells has not been studied longitudinally. Here, we report that the proportions of Lin-CD34+38- hematopoietic multipotent cells (HMCs) and of Lin-CD34+CD38+ hematopoietic...
10.
Tolu S, Wang K, Yan Z, Zhang S, Roberts K, Crouch A, et al.
Cells
. 2020 Sep;
9(10).
PMID: 32987729
The consequences of sickle cell disease (SCD) include ongoing hematopoietic stress, hemolysis, vascular damage, and effect of chronic therapies, such as blood transfusions and hydroxyurea, on hematopoietic stem and progenitor...